Expression of novel neuroendocrine markers in breast carcinomas: a study of INSM1, ASCL1, and POU2F3.

MLA

Zhong, Elaine, et al. “Expression of Novel Neuroendocrine Markers in Breast Carcinomas: A Study of INSM1, ASCL1, and POU2F3.” Human Pathology, vol. 127, Sept. 2022, pp. 102–11. EBSCOhost, https://doi.org/10.1016/j.humpath.2022.06.003.

APA

Zhong, E., Pareja, F., Hanna, M. G., Jungbluth, A. A., Rekhtman, N., & Brogi, E. (2022). Expression of novel neuroendocrine markers in breast carcinomas: a study of INSM1, ASCL1, and POU2F3. Human Pathology, 127, 102–111. https://doi.org/10.1016/j.humpath.2022.06.003

Chicago

Zhong, Elaine, Fresia Pareja, Matthew G Hanna, Achim A Jungbluth, Natasha Rekhtman, and Edi Brogi. 2022. “Expression of Novel Neuroendocrine Markers in Breast Carcinomas: A Study of INSM1, ASCL1, and POU2F3.” Human Pathology 127 (September): 102–11. doi:10.1016/j.humpath.2022.06.003.